In our previous investigation, we developed an efficient approach to produce DC/tumor-associated fibroblasts-fusion cells, and tumor-specific CD8+ T cells were successfully induced and substantial antitumor responses were achieved in preclinical in vitro and in vivo through this approach [11]. This evidence concerns the gene CD8A and neoplasm.